TC, its just discerning to have to start all over at a low pps when we were at $3.10 even if it was for an instant. Just seems when we make some upward movement, we pay a significant price later. If indeed the company has added value from all the acquisitions and forward looking revenue, then why such a downturn? And to top it off, uplisting now seems like a distant dream.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links